Pro Medicus, Ltd.Pro Medicus, Ltd.Pro Medicus, Ltd.

Pro Medicus, Ltd.

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪9.68 B‬EUR
0.62EUR
‪64.32 M‬EUR
‪118.89 M‬EUR
‪53.06 M‬
Beta (1Y)
1.69
Employees (FY)
132
Revenue / Employee (1Y)
‪900.68 K‬EUR
Net income / Employee (1Y)
‪487.25 K‬EUR

About Pro Medicus, Ltd.


CEO
Sam Aaron Hupert
Headquarters
Richmond
Founded
1983
IPO date
Oct 10, 2000
Identifiers
2
ISIN AU000000PME8
Pro Medicus Ltd. engages in the development and supply of healthcare imaging software, Radiology Information System (RIS), and services to hospitals. It operates through the following geographical segments: Australia, Europe, and North America. The firm’s products include Visage 7 and Visage RIS. The company was founded by Sam Aaron Hupert and Anthony Barry Hall in 1983 and is headquartered in Richmond, Australia.

Check out other big names from the same industry as PMC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
VAS
Vanguard Australian Shares Index ETF
Weight
0.44%
Market value
‪140.75 M‬
USD
VXUS
Vanguard Total International Stock ETF
Weight
0.02%
Market value
‪114.48 M‬
USD
VEA
Vanguard FTSE Developed Markets ETF
Weight
0.03%
Market value
‪73.63 M‬
USD
IEFA
iShares Core MSCI EAFE ETF
Weight
0.03%
Market value
‪45.16 M‬
USD
DACE
Dimensional Australian Core Equity Trust Units
Weight
0.92%
Market value
‪39.29 M‬
USD
A200
BetaShares Australia 200 ETF
Weight
0.37%
Market value
‪23.78 M‬
USD
ATEC
BETASHARES S&P/ASX AUSTRALIAN TECHNOLOGY ETF
Weight
8.11%
Market value
‪22.62 M‬
USD
EFA
iShares MSCI EAFE ETF
Weight
0.03%
Market value
‪22.54 M‬
USD
MVW
VanEck Australian Equal Weight ETF
Weight
0.88%
Market value
‪19.28 M‬
USD
IOZ
iShares Core S&P/ASX 200 ETF
Weight
0.33%
Market value
‪17.99 M‬
USD
BBAX
JPMorgan BetaBuilders Developed Asia Pacific ex-Japan ETF
Weight
0.29%
Market value
‪17.78 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of PMC is 96.00 EUR — it has increased by 1.05% in the past 24 hours. Watch Pro Medicus, Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Pro Medicus, Ltd. stocks are traded under the ticker PMC.
PMC stock has fallen by −10.28% compared to the previous week, the month change is a −17.24% fall, over the last year Pro Medicus, Ltd. has showed a −17.24% decrease.
We've gathered analysts' opinions on Pro Medicus, Ltd. future price: according to them, PMC price has a max estimate of 207.91 EUR and a min estimate of 133.66 EUR. Watch PMC chart and read a more detailed Pro Medicus, Ltd. stock forecast: see what analysts think of Pro Medicus, Ltd. and suggest that you do with its stocks.
PMC reached its all-time high on Jan 16, 2026 with the price of 122.00 EUR, and its all-time low was 100.00 EUR and was reached on Jan 26, 2026. View more price dynamics on PMC chart.
See other stocks reaching their highest and lowest prices.
PMC stock is 5.49% volatile and has beta coefficient of 1.69. Track Pro Medicus, Ltd. stock price on the chart and check out the list of the most volatile stocks — is Pro Medicus, Ltd. there?
Today Pro Medicus, Ltd. has the market capitalization of ‪9.68 B‬, it has increased by 1.46% over the last week.
Yes, you can track Pro Medicus, Ltd. financials in yearly and quarterly reports right on TradingView.
Pro Medicus, Ltd. is going to release the next earnings report on Feb 12, 2026. Keep track of upcoming events with our Earnings Calendar.
PMC earnings for the last half-year are 0.34 EUR per share, whereas the estimation was 0.32 EUR, resulting in a 4.38% surprise. The estimated earnings for the next half-year are 0.38 EUR per share. See more details about Pro Medicus, Ltd. earnings.
Pro Medicus, Ltd. revenue for the last half-year amounts to ‪64.61 M‬ EUR, despite the estimated figure of ‪64.63 M‬ EUR. In the next half-year revenue is expected to reach ‪73.04 M‬ EUR.
PMC net income for the last half-year is ‪35.43 M‬ EUR, while the previous report showed ‪30.92 M‬ EUR of net income which accounts for 14.58% change. Track more Pro Medicus, Ltd. financial stats to get the full picture.
Pro Medicus, Ltd. dividend yield was 0.19% in 2025, and payout ratio reached 49.87%. The year before the numbers were 0.28% and 50.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 7, 2026, the company has 132 employees. See our rating of the largest employees — is Pro Medicus, Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pro Medicus, Ltd. EBITDA is ‪92.06 M‬ EUR, and current EBITDA margin is 77.44%. See more stats in Pro Medicus, Ltd. financial statements.
Like other stocks, PMC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pro Medicus, Ltd. stock right from TradingView charts — choose your broker and connect to your account.